Pancreatic neuroendocrine tumors: Surgical outcomes and survival analysis

Joseph N. Fahmy, M. Alyssa Varsanik, Daniel Hubbs, Emanuel Eguia, Gerard Abood, Lawrence M. Knab

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Background: Pancreatic neuroendocrine tumors are rare, with rising incidence and limited clinicopathological studies. Methods: Adult patients with pNET at a single tertiary care center were retrospectively evaluated. Results: In total, 87 patients with histologically confirmed pNET who underwent resection were evaluated. 11% of patients had functioning pNETs: 9 insulinoma and 1 VIPoma. The majority (88.5%) were nonfunctioning. The most common surgical procedure performed was distal pancreatectomy with splenectomy (36.8%). 35.6% of cases were performed with minimally invasive surgery (MIS). MIS patients had fewer postoperative complications, shorter length of stay, and fewer ICU admissions.Disease-free survival (DFS) was unaffected by tumor size (p = 0.5) or lymph node status (p = 0.62). Patients with high-grade (G3) tumors experienced significantly shorter DFS (p = 0.02). Conclusions: This series demonstrates that survival in patients with pNET is driven mostly by tumor grade, though overall most have long-term survival after surgical resection. Additionally, an MIS approach is efficacious in appropriately selected cases. Survival for pancreatic neuroendocrine tumors is driven mostly by tumor grade. Minimally invasive surgery is a safe and effective approach to resecting these tumors.

Original languageEnglish (US)
Pages (from-to)529-533
Number of pages5
JournalAmerican Journal of Surgery
Volume221
Issue number3
DOIs
StatePublished - Mar 2021

All Science Journal Classification (ASJC) codes

  • Surgery

Fingerprint

Dive into the research topics of 'Pancreatic neuroendocrine tumors: Surgical outcomes and survival analysis'. Together they form a unique fingerprint.

Cite this